FORT MYERS, Fla.,
April 19,
2024 /PRNewswire/ -- MGI Tech, a company committed to
building core tools and technology to lead life science, is proud
to announce that its DNBSEQ-T20x2* gene sequencer has been
recognized with a Gold Edison Award in the "Health, Medical
& Biotech" category.
"MGI is dedicated to unlocking the future of genomic
technologies and pursuing excellence in building life science core
tools," said Duncan Yu, President of
MGI. "It is our pleasure and honor to be awarded the Edison Award
for the first time. This recognition affirms our team's efforts in
intelligent innovation as we continue to achieve outstanding
results on the global stage."
Named after the prolific inventor Thomas
A. Edison, the Edison Awards is one of the most prestigious
technology accolades honoring excellence in new product
development, design, and innovation. Thousands of innovations from
around the world were reviewed by senior scientists, designers,
engineers, marketers, and leading academics based on the four
criteria of concept, value, delivery, and impact. The "Health,
Medical & Biotech" category, in particular, honors products and
services that have made a profound impact on patients and
healthcare providers.
MGI's groundbreaking DNBSEQ-T20x2* ultra-high-throughput
sequencer has been garnering significant attention since its debut
in February 2023 for reducing genome
sequencing costs to less than $100
per genome. This remarkable feat is not only facilitating the
sequencing of a larger number of samples, but also empowering a
more comprehensive, insightful, and precise analysis per
sample.
The commercial success of DNBSEQ-T20x2* has enhanced overall
sequencing capabilities and accelerated global scientific advances
by doubling the efficiency of DNA sequencing. With its unparalleled
throughput and exceptional cost-effectiveness, the sequencer is
contributing to the development of the global genetic industry and
driving progress in understanding the human genome and various
medical applications.
Since its introduction, DNBSEQ-T20×2* has been received
positively by leading global research institutions and healthcare
providers, with corporate orders from the Shanghai-based JMDNA Biomedical Technology
Co., Ltd, Prepaire Labs, a healthcare technology company in
Abu Dhabi, and Eurofins Genomics,
one of the key emerging players in specialty esoteric and molecular
clinical diagnostic testing in Europe and the
United States.
In addition to the Edison Award, DNBSEQ-T20×2* has also garnered
numerous recognitions, including the 2023 R&D 100 Awards,
BEYOND Healthcare Innovation Award, 2023 BioTech Breakthrough
Awards, and 2023 Globee® Awards, for its cutting-edge innovation
and positive impact on global health.
For more information about the DNBSEQ-T20x2* gene sequencer,
visit https://en.mgi-tech.com/products/instruments_info/33/.
###
About MGI
MGI Tech Co. Ltd. (or its subsidiaries, together referred to
MGI), headquartered in Shenzhen,
is committed to building core tools and technology to lead life
science through intelligent innovation. Based on its proprietary
technology, MGI focuses on research & development, production
and sales of sequencing instruments, reagents, and related products
to support life science research, agriculture, precision medicine
and healthcare. MGI is a leading producer of clinical
high-throughput gene sequencers*, and its multi-omics platforms
include genetic sequencing*, medical imaging, and laboratory
automation. MGI's mission is to develop and promote advanced life
science tools for future healthcare. For more information,
please visit the MGI website or connect with us
on Twitter, LinkedIn or YouTube.
*For now, this product is provided for Research Use Only and not
for use in diagnostic procedures.
About Edison Awards™
Established in 1987, the Edison Awards are dedicated to
recognizing, honoring and fostering innovations and innovators.
Named after Thomas Alva Edison (1847-1931), the annual
competition honors excellence in new product and service
development, marketing, design and innovation. Past award
recipients include Steve Jobs, Elon Musk, and leaders of
global corporations such as Coca-Cola, Genentech, General Electric,
General Motors, IBM and Campbell Soup Co. In 2021, the Edison
Awards introduced the inaugural Lewis Latimer Fellowship program
designed to celebrate, connect and bring together a community of
innovative Black thought leaders. For more information,
visit www.edisonawards.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/mgi-techs-dnbseq-t20x2-gene-sequencer-named-2024-edison-award-gold-winner-302122058.html
SOURCE MGI